Dr. Reddy’s, Promius Pharma file NDA for migraine candidate with USFDA

03 Apr 2018 Evaluate

Dr. Reddy’s Laboratories and its US subsidiary Promius Pharma LLC have filed New Drug Application (NDA) for its migraine candidate DFN-02 with the US Food and Drug Administration (USFDA).

The filing of DFN-02 NDA represents the company’s continuing commitment to bring innovative solutions in migraine treatment.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1267.90 -7.15 (-0.56%)
08-Dec-2025 13:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1796.40
Dr. Reddys Lab 1267.90
Cipla 1506.45
Zydus Lifesciences 925.50
Lupin 2069.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×